China NMPA Drug Inspection - Hunan Ranruntang Traditional Chinese Medicine Co., Ltd. - Cassia seeds
China NMPA drug inspection for Hunan Ranruntang Traditional Chinese Medicine Co., Ltd. published December 27, 2017. Drug: Cassia seeds. The Chongqing Municipal Food and Drug Administration (CFDA) published its 6th Drug Quality Announcement of 2017 on Decem
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Hunan Ranruntang Traditional Chinese Medicine Co., Ltd. published December 27, 2017. Drug: Cassia seeds. The Chongqing Municipal Food and Drug Administration (CFDA) published its 6th Drug Quality Announcement of 2017 on Decem
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox